ADCE-T02, a potential best-in-class Tissue Factor targeted antibody-drug conjugate (ADC), enters cohort expansion portion of the Tiffany-01 study in advanced solid tumors; Two ADC ...

Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that an abstract highlighting data on its lead drug candidate, annamycin, has been accepted for poster ...

Tubulis today announced that an abstract covering current clinical trial data from its ongoing Phase I/IIa NAPISTAR 1-01 trial (NCT06303505) has been accepted for a rapid oral presentation at the ...

Since 1971, the Southern Poverty Law Center worked closely with the FBI and DOJ against hate groups. Now the feds have ...

The American Chemical Society (ACS) Fellows Program was created by the ACS Board of Directors in December 2008 to recognize members of the ACS for outstanding achievements and contributions to science ...

Fapon Biopharma, a clinical-stage biotech company innovating therapeutic antibodies and fusion proteins, is pleased to announce its participation in the AACR Annual Meeting 2026, taking place April 19 ...

Before long, busy faculty members begin to skip the time-consuming task of discussing pedagogy within their departments, ...

Rgenta Therapeutics, a clinical-stage biotechnology company pioneering the development of a new class of oral small molecules targeting RNA and RNA regulation ...

Programmers learning Rust struggle to understand own\x02ership types, Rust’s core mechanism for ensuring memory safety ...

Positive high-level results from the pivotal Phase III MIRANDA trial showed potential first-in-class tozorakimab demonstrated a statistically significant and clinically meaningful reduction in the ...

In April, the American Red Cross asks people to keep patients top of mind by making an appointment to give blood or platelets ...

New preclinical data, independently presented in two posters at the 2026 American Association for Cancer Research (AACR) Annual Meeting, show positive effects of opaganib[1] ...